Johnson Chemical Pharmaceutical Works Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 13, 2021 at 04:08 am IST
Share
Johnson Chemical Pharmaceutical Works Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 98.855 million compared to TWD 97.459 million a year ago. Operating income was TWD 16.207 million compared to TWD 18.335 million a year ago. Net income was TWD 12.867 million compared to TWD 17.728 million a year ago. Basic earnings per share from continuing operations was TWD 0.43 compared to TWD 0.59 a year ago. For the half year, sales was TWD 204.640 million compared to TWD 215.245 million a year ago. Operating income was TWD 29.334 million compared to TWD 41.042 million a year ago. Net income was TWD 23.316 million compared to TWD 36.067 million a year ago. Basic earnings per share from continuing operations was TWD 0.78 compared to TWD 1.2 a year ago.
Johnson Chemical Pharmaceutical Works Co., Ltd. is a Taiwan-based company principally engaged in the manufacture and distribution of western medicines and the related raw materials. The Company mainly provides solid dosage forms, including soft and hard capsules, sugar coated tablets, film-coated tablets, suppositories, powder, granules, tablets and others. The Companyâs products include central nervous system drugs, hormones and hormone function medicines, respiratory medicines, gastrointestinal drugs, vitamins and others. The Company mainly distributes its products in Taiwan market and the rest of Asia.
JOHNSON CHEMICAL PHARMACEUTICAL WORKS CO., LTD. 
